Frontiers in Rheumatoid Arthritis: Emerging Research and Unmet Needs in Pharmacologic Management
The management of rheumatoid arthritis (RA) has undergone several practice-defining evolutions, beginning with the approval of low-dose methotrexate and continuing through the introduction of numerous disease-modifying antirheumatic drugs (DMARDs). With increasing capability to target pro-inflammato...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2026-01-01
|
| Серии: | Pharmaceuticals |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/1424-8247/19/2/218 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|